On the 28th, DeepNoid announced that it has completed the approval process with the Ministry of Food and Drug Safety for 'DeepNeuro BrainSeg (DEEP:NEURO BrainSeg)', a software medical device that automatically analyzes brain MRI images.
DeepNeuro BrainSeg automatically segments major anatomical structures in brain MRIs and provides volume data and percentile information relative to reference standards by region. It compares current scans with previous ones to track structural changes over time and automatically calculates MRPI, a quantitative indicator used for Parkinson’s disease evaluation.
Previously, quantitative analysis of brain MRIs required skilled personnel to manually identify and measure structures. DeepNoid explained that its solution automates this process, reducing the workload involved in interpretation and standardizing analysis results.
Analysis results are delivered as integrated reports and can be linked with medical institutional PACS systems. Medical teams can also use them to review interpretation findings and explain or consult with patients.
With this approval, DeepNoid has expanded its brain imaging AI business scope. While the existing 'DeepNeuro' product line focused on detecting cerebrovascular lesions using MRA images, the addition of BrainSeg extends its capabilities to include quantitative analysis of brain structures based on MRI. The company stated that it can also be applied to image analysis related to degenerative brain diseases such as dementia and Parkinson’s disease.
Earlier this month, DeepNoid also completed approval for 'AxonFlow', a remote interpretation operation platform. The company plans to expand its medical AI business by integrating interpretation AI with operational platforms to support the entire clinical workflow.
Choi Woo-sik, CEO of DeepNoid, said, "This product standardizes brain quantitative analysis that previously relied on manual work, substantially reducing the interpretive burden on medical staff," and added, "We will transform into a medical AI agent company that supports the entire clinical process."
in TECH
